Drugs Made In America Acquisition II Corp. (DMII) Notes Payables (2024 - 2026)

Drugs Made In America Acquisition (DMII) has reported Notes Payables for 2 consecutive years, with $450000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Notes Payables changed N/A year-over-year to $450000.0 in Q2 2026; TTM through Jun 2026 was $450000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $250100.0, changed N/A from the prior year.
• Notes Payables was $450000.0 for Q2 2026 at Drugs Made In America Acquisition, up from $250100.0 in the prior quarter.
• Over five years, Notes Payables peaked at $450000.0 in Q2 2026 and troughed at $250100.0 in Q4 2024.